Reaction Details Report a problem with these data
Target
Cyclin-dependent kinase 9
Ligand
BDBM50261273
Substrate
n/a
Meas. Tech.
ChEBML_1695713
Ki
108±n/a nM
Citation
 Liang, J; Van Abbema, A; Balazs, M; Barrett, K; Berezhkovsky, L; Blair, WS; Chang, C; Delarosa, D; DeVoss, J; Driscoll, J; Eigenbrot, C; Goodacre, S; Ghilardi, N; MacLeod, C; Johnson, A; Bir Kohli, P; Lai, Y; Lin, Z; Mantik, P; Menghrajani, K; Nguyen, H; Peng, I; Sambrone, A; Shia, S; Smith, J; Sohn, S; Tsui, V; Ultsch, M; Williams, K; Wu, LC; Yang, W; Zhang, B; Magnuson, S Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model. Bioorg Med Chem Lett 27:4370-4376 (2017) [PubMed]  Article 
Target
Name:
Cyclin-dependent kinase 9
Synonyms:
C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit
Type:
Enzyme Subunit
Mol. Mass.:
42789.13
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
372
Sequence:
MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNPATTNQTEFERVF
  
Inhibitor
Name:
BDBM50261273
Synonyms:
CHEMBL4076947
Type:
Small organic molecule
Emp. Form.:
C18H11Cl2N7
Mol. Mass.:
396.233
SMILES:
Cc1cc(Nc2nccc3nc([nH]c23)-c2c(Cl)cc(cc2Cl)C#N)ncn1
Structure:
Search PDB for entries with ligand similarity: